Dithranol
Application Notes
Dithranol, a potential anti-psoriasis medication, may be used to study its safety, efficacy, metabolism and pharmacological profile. Dithranol may be used to study is physicochemical properties, as a reference compound and to develop effective drug delivery vehicles. Dithranol may be used as a matrix for matrix assisted laser desorption/ionization imaging on a Fourier transform ion cyclotron resonance mass spectrometer.
Usage Statement
Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department.
Key Applications
Apoptosis
SKU | 02191502-CF |
Alternate Names | Anthralin; 1,8 Dihydroxyanthrone; 1,8,9-Anthracenetriol; 1,8-Dihydroxy-9(10H)-anthracenone |
Application Notes | Dithranol, a potential anti-psoriasis medication, may be used to study its safety, efficacy, metabolism and pharmacological profile. Dithranol may be used to study is physicochemical properties, as a reference compound and to develop effective drug delivery vehicles. Dithranol may be used as a matrix for matrix assisted laser desorption/ionization imaging on a Fourier transform ion cyclotron resonance mass spectrometer. |
Base Catalog Number | 191502 |
Beilstein Registry Number | 2054360 |
CAS # | 1143-38-0 |
EC Number | 214-538-0 |
Format | Powder |
Hazard Statements | H315-H319-H335 |
Melting Point | 349 to 358° F (NTP, 1992) |
Molecular Formula | C14H10O3 |
Molecular Weight | 226.231 g/mol |
Personal Protective Equipment | Dust mask, Eyeshields, Gloves |
Purity | ≥99% |
RTECS Number | CB8927000 |
Safety Symbol | GHS07 |
Solubility | less than 1 mg/mL at 68° F (NTP, 1992) |
Usage Statement | Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department. |